North America Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

May 2017 | 115 pages | ID: N3AFE196FE6EN
GlobalInfoResearch

Abstracts

'Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.'

Scope of the Report:

This report focuses on the Onychomycosis (Tinea Unguium) Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Johnson & Johnson
• GSK
• Novartis
• Pfizer
• Valeant Pharma
• Kaken Pharmaceutical
• Galderma
• Xiuzheng Pharmaceutical
• Letai
• Qilu Pharmaceutical

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Oral
• External

Market Segment by Applications, can be divided into

• Age under 18
• Age 18-50
• Age above 50

There are 15 Chapters to deeply display the North America Onychomycosis (Tinea Unguium) Drug market.

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Onychomycosis (Tinea Unguium) Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Onychomycosis (Tinea Unguium) Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Onychomycosis (Tinea Unguium) Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Oral
  1.2.2 External
1.3 Market Analysis by Applications
  1.3.1 Age under
  1.3.2 Age 18-50
  1.3.3 Age above
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Johnson & Johnson
  2.1.1 Profile
  2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Johnson & Johnson News
2.2 GSK
  2.2.1 Profile
  2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 GSK News
2.3 Novartis
  2.3.1 Profile
  2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Novartis News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 Valeant Pharma
  2.5.1 Profile
  2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Valeant Pharma News
2.6 Kaken Pharmaceutical
  2.6.1 Profile
  2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Kaken Pharmaceutical News
2.7 Galderma
  2.7.1 Profile
  2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Galderma News
2.8 Xiuzheng Pharmaceutical
  2.8.1 Profile
  2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Xiuzheng Pharmaceutical News
2.9 Letai
  2.9.1 Profile
  2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Letai News
2.10 Qilu Pharmaceutical
  2.10.1 Profile
  2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Qilu Pharmaceutical News

3 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
  3.4.2 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET ANALYSIS BY COUNTRIES

4.1 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries
4.2 North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2012-2017)
4.3 North America Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY TYPE

5.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
  5.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
5.2 Oral Sales Growth and Price
  5.2.1 North America Oral Sales Growth (2012-2017)
  5.2.2 North America Oral Price (2012-2017)
5.3 External Sales Growth and Price
  5.3.1 North America External Sales Growth (2012-2017)
  5.3.2 North America External Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY APPLICATION

6.1 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
6.2 Age under 18 Sales Growth (2012-2017)
6.3 Age 18-50 Sales Growth (2012-2017)
6.4 Age above 50 Sales Growth (2012-2017)

7 UNITED STATES ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
7.3 United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
7.4 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer
  7.4.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer
7.5 United States Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)

8 CANADA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
8.3 Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
8.4 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer
  8.4.2 Canada Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer
8.5 Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)

9 MEXICO ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
9.3 Mexico Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
9.4 Mexico Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer
  9.4.2 Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer
9.5 Mexico Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)

10 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST (2017-2022)

10.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Countries (2017-2022)
  10.2.1 United States Onychomycosis (Tinea Unguium) Drug Forecast (2017-2022)
  10.2.2 Canada Onychomycosis (Tinea Unguium) Drug Forecast (2017-2022)
  10.2.3 Mexico Onychomycosis (Tinea Unguium) Drug Forecast (2017-2022)
10.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2017-2022)
10.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2017-2022)

11 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MANUFACTURING COST ANALYSIS

11.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Onychomycosis (Tinea Unguium) Drug Picture
Table Product Specifications of Onychomycosis (Tinea Unguium) Drug
Figure North America Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Types in 2016
Table Types of Onychomycosis (Tinea Unguium) Drug
Figure Oral Picture
Table Major Manufacturers of Oral
Figure External Picture
Table Major Manufacturers of External
Table North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications in 2016
Table Applications of Onychomycosis (Tinea Unguium) Drug
Figure Age under 18 Picture
Figure Age 18-50 Picture
Figure Age above 50 Picture
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Onychomycosis (Tinea Unguium) Drug Type and Applications
Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharma Basic Information, Manufacturing Base and Competitors
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Xiuzheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Letai Basic Information, Manufacturing Base and Competitors
Table Letai Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table North America Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)
Figure Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2016
Figure Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017
Figure Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2016
Figure Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017
Figure North America Onychomycosis (Tinea Unguium) Drug Sales and Growth (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2012-2017)
Figure North America 2012 Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries
Figure North America 2016 Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue and Growth (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2012-2017)
Table North America 2012 Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries
Table North America 2016 Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2012-2017)
Figure North America Oral Sales Growth (2012-2017)
Figure North America Oral Price (2012-2017)
Figure North America External Sales Growth (2012-2017)
Figure North America External Price (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2012-2017)
Figure North America Age under 18 Sales Growth (2012-2017)
Figure North America Age 18-50 Sales Growth (2012-2017)
Figure North America Age above 50 Sales Growth (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales and Growth (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table United States Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table United States Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue and Growth (2012-2017)
Figure Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth (2012-2017)
Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Type (2012-2017)
Table Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
Table Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Canada Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Growth (2012-2017)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Sales and Growth (2012-2017)
Table Mexico Onychomycosis (Tinea Unguium) Drug Sales by Type (2012-2017)
Table Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Table Mexico Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
Table Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Table Mexico Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Mexico Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Mexico Onychomycosis (Tinea Unguium) Drug Export and Import (2012-2017)
Figure North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Countries (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Countries (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Forecast (2017-2022)
Figure Canada Onychomycosis (Tinea Unguium) Drug Sales Forecast (2017-2022)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Sales Forecast (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)
Table North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
Table Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2016
Table Major Buyers of Onychomycosis (Tinea Unguium) Drug
Table Distributors/Traders/ Dealers List